Healthcare Triangle Inc. (HCTI) Financial Statements (2024 and earlier)
Company Profile
Business Address |
4309 HACIENDA DR. PLEASANTON, CA 945888 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 7373 - Computer Integrated Systems Design (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
---|---|---|---|---|---|---|
ASSETS | ||||||
Current Assets | ||||||
Cash, cash equivalents, and short-term investments | 1,234 | 1,341 | 1,770 | |||
Cash and cash equivalents | 1,234 | 1,341 | 1,770 | |||
Receivables | 3,236 | 5,592 | 9,672 | |||
Other current assets | 1,259 | 816 | 361 | |||
Total current assets: | 5,729 | 7,749 | 11,803 | |||
Noncurrent Assets | ||||||
Operating lease, right-of-use asset | 172 | |||||
Property, plant and equipment | 44 | 80 | 74 | |||
Intangible assets, net (including goodwill) | 1,875 | 11,859 | 11,746 | |||
Goodwill | (1,736) | 1,289 | 1,289 | |||
Intangible assets, net (excluding goodwill) | 3,611 | 10,570 | 10,458 | |||
Other undisclosed noncurrent assets | 2,401 | 1,075 | 816 | |||
Total noncurrent assets: | 4,320 | 13,014 | 12,809 | |||
TOTAL ASSETS: | 10,049 | 20,763 | 24,613 | |||
LIABILITIES AND EQUITY | ||||||
Liabilities | ||||||
Current Liabilities | ||||||
Accounts payable and accrued liabilities | 1,953 | 1,481 | 1,928 | |||
Accounts payable | 1,953 | 1,481 | 1,873 | |||
Accrued liabilities | 55 | |||||
Debt | 3,429 | 2,412 | 2,209 | |||
Other liabilities | 1,787 | 2,200 | 869 | |||
Other undisclosed current liabilities | 954 | 55 | 1,245 | |||
Total current liabilities: | 8,123 | 6,148 | 6,251 | |||
Noncurrent Liabilities | ||||||
Long-term debt and lease obligation | 888 | |||||
Long-term debt, excluding current maturities | 888 | |||||
Other undisclosed noncurrent liabilities | 500 | 2,227 | 2,227 | |||
Total noncurrent liabilities: | 1,388 | 2,227 | 2,227 | |||
Total liabilities: | 9,511 | 8,375 | 8,478 | |||
Equity | ||||||
Equity, attributable to parent, including: | 538 | 12,478 | 16,135 | |||
Common stock | 0 | |||||
Additional paid in capital | 25,443 | 24,956 | 18,799 | |||
Accumulated deficit | (24,905) | (12,568) | (2,664) | |||
Other undisclosed equity, attributable to parent | 90 | 0 | ||||
Other undisclosed equity | (91) | |||||
Total equity: | 538 | 12,387 | 16,135 | |||
Other undisclosed liabilities and equity | 1 | |||||
TOTAL LIABILITIES AND EQUITY: | 10,049 | 20,763 | 24,613 |
Income Statement (P&L) ($ in thousands)
6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
---|---|---|---|---|---|
Revenues | 33,203 | 45,886 | 35,270 | ||
Cost of revenue | (26,426) | (34,591) | (24,748) | ||
Other undisclosed gross profit | 1,063,223 | ||||
Gross profit: | 1,070,000 | 11,295 | 10,521 | ||
Operating expenses | (18,125) | (21,711) | (15,880) | ||
Other undisclosed operating loss | (1,063,223) | ||||
Operating loss: | (11,348) | (10,416) | (5,359) | ||
Nonoperating income (expense) | 1,087 | (567) | |||
Other nonoperating income | 1,087 | ||||
Interest and debt expense | (968) | (212) | (567) | ||
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (5) | 567 | |||
Loss from continuing operations before equity method investments, income taxes: | (12,316) | (9,546) | (5,926) | ||
Other undisclosed income (loss) from continuing operations before income taxes | 12 | (1) | |||
Loss from continuing operations before income taxes: | (12,304) | (9,547) | (5,926) | ||
Income tax expense | (35) | (63) | (24) | ||
Loss from continuing operations: | (12,339) | (9,610) | (5,950) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (5,950) | |
Other undisclosed net income | 11,938 | 1 | |||
Net loss: | (401) | (9,609) | (5,950) | ||
Other undisclosed net loss attributable to parent | (11,938) | (1) | |||
Net loss attributable to parent: | (12,339) | (9,610) | (5,950) | ||
Other undisclosed net income available to common stockholders, basic | 1 | ||||
Net loss available to common stockholders, diluted: | (12,339) | (9,609) | (5,950) |
Comprehensive Income ($ in thousands)
6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
---|---|---|---|---|---|
Net loss: | (401) | (9,609) | (5,950) | ||
Comprehensive loss, net of tax, attributable to parent: | (401) | (9,609) | (5,950) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.